Literature DB >> 7808383

Dengue type 3 infection--Nicaragua and Panama, October-November 1994.

.   

Abstract

The geographic range and incidence of dengue virus activity in the Americas substantially increased from 1980 to 1994. During this period, all dengue activity in the Americas was associated with dengue serotypes 1, 2, and 4 (DEN-1, DEN-2, and DEN-4). On November 25, 1994, the Ministry of Health of Nicaragua announced the isolation of dengue type 3 (DEN-3) from two children hospitalized with minor hemorrhagic manifestations in Managua. Subsequently, DEN-3 virus was isolated from two persons with dengue fever in Panama. These cases represent the first isolation of DEN-3 from autochthonous cases in the Americas since 1977. This report describes these cases and dengue activity in Nicaragua and Panama and summarizes public health activities to control dengue fever in the Americas.

Entities:  

Mesh:

Year:  1995        PMID: 7808383

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  12 in total

1.  Prolonged co-circulation of two distinct Dengue virus Type 3 lineages in the hyperendemic area of Medellin, Colombia.

Authors:  Marta C Ospina; Francisco J Diaz; Jorge E Osorio
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

2.  Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR.

Authors:  E Harris; T G Roberts; L Smith; J Selle; L D Kramer; S Valle; E Sandoval; A Balmaseda
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

3.  The history of dengue outbreaks in the Americas.

Authors:  Olivia Brathwaite Dick; José L San Martín; Romeo H Montoya; Jorge del Diego; Betzana Zambrano; Gustavo H Dayan
Journal:  Am J Trop Med Hyg       Date:  2012-10       Impact factor: 2.345

4.  Phylogeography and population dynamics of dengue viruses in the Americas.

Authors:  Orchid M Allicock; Philippe Lemey; Andrew J Tatem; Oliver G Pybus; Shannon N Bennett; Brandi A Mueller; Marc A Suchard; Jerome E Foster; Andrew Rambaut; Christine V F Carrington
Journal:  Mol Biol Evol       Date:  2012-01-06       Impact factor: 16.240

5.  Origin and evolution of dengue virus type 3 in Brazil.

Authors:  Josélio Maria Galvão de Araújo; Gonzalo Bello; Hector Romero; Rita Maria Ribeiro Nogueira
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

6.  Circulation of different lineages of dengue virus type 2 in Central America, their evolutionary time-scale and selection pressure analysis.

Authors:  Germán Añez; Maria E Morales-Betoulle; Maria Rios
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

7.  Evolution and epidemiologic dynamics of dengue virus in Nicaragua during the emergence of chikungunya and Zika viruses.

Authors:  Sean V Edgerton; Panpim Thongsripong; Chunling Wang; Magelda Montaya; Angel Balmaseda; Eva Harris; Shannon N Bennett
Journal:  Infect Genet Evol       Date:  2020-12-14       Impact factor: 4.393

8.  Dengue 3 epidemic, Havana, 2001.

Authors:  Otto Peláez; María G Guzmán; Gustavo Kourí; Raúl Pérez; José L San Martín; Susana Vázquez; Delfina Rosario; Regla Mora; Ibrahim Quintana; Juan Bisset; Reynel Cancio; Ana M Masa; Osvaldo Castro; Daniel González; Luis C Avila; Rosmari Rodríguez; Mayling Alvarez; Jose L Pelegrino; Lídice Bernardo; Irina Prado
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

9.  Re-emergence of dengue virus type 3 in Canton, China, 2009-2010, associated with multiple introductions through different geographical routes.

Authors:  Huiying Liang; Lei Luo; Zhicong Yang; Biao Di; Zhijun Bai; Peng He; Qinlong Jing; Xueli Zheng
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Comparative analysis of full genomic sequences among different genotypes of dengue virus type 3.

Authors:  Chwan-Chuen King; Day-Yu Chao; Li-Jung Chien; Gwong-Jen J Chang; Ting-Hsiang Lin; Yin-Chang Wu; Jyh-Hsiung Huang
Journal:  Virol J       Date:  2008-05-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.